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Background: Local protein synthesis (LPS) via receptor-mediated signaling plays a role in the directional responses
of axons to extrinsic cues. An intact cytoskeleton is critical to enact these responses, but it is not known
whether the two major cytoskeletal elements, F-actin and microtubules, have any roles in regulating axonal
protein synthesis.
Results: Here, we show that pharmacological disruption of either microtubules or actin filaments in growth
cones blocks netrin-1-induced de novo synthesis of proteins, as measured by metabolic incorporation of
labeled amino acids, implicating both elements in axonal synthesis. However, comparative analysis of the
activated translation initiation regulator, eIF4E-BP1, revealed a striking difference in the point of action of the
two elements: actin disruption completely inhibited netrin-1-induced eIF4E-BP1 phosphorylation while
microtubule disruption had no effect. An intact F-actin, but not microtubule, cytoskeleton was also required
for netrin-1-induced activation of the PI3K/Akt/mTOR pathway, upstream of translation initiation. Downstream
of translation initiation, microtubules were required for netrin-1-induced activation of eukaryotic elongation
factor 2 kinase (eEF2K) and eEF2.
Conclusions: Taken together, our results show that while actin and microtubules are both crucial for cue-induced
axonal protein synthesis, they serve distinct roles with F-actin being required for the initiation of translation and
microtubules acting later at the elongation step.Background
The ability of neuronal growth cones to synthesize pro-
teins locally helps to control various aspects of axon
growth and guidance. Turning and collapse responses
[1-9], chemotropic adaptation [3,10,11], and the local
upregulation of specific receptors and adhesion mole-
cules allowing growth cones to move on from intermedi-
ate targets [12-15] all involve local protein synthesis
(LPS). LPS depends on targeting mRNAs to the correct
subcellular location and on the local activation of trans-
lational machinery, thus ensuring the synthesis of par-
ticular proteins at the proper time and place. In* Correspondence: ceh33@cam.ac.uk
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unless otherwise stated.developing retinal ganglion cells (RGCs) in Xenopus, the
guidance cue netrin-1 triggers the transport of the zip-
code binding protein 1 (ZBP1; known as Vg1RBP in
Xenopus) into growth cone filopodia [5]. ZBP1 is respon-
sible for the localization of several species of mRNA, in
part, by binding to their cis-acting ‘zipcodes’ which are
located in the 3′ untranslated regions (3′ UTRs) of
mRNA targets, and together, they are transported as
translationally dormant ribonucleoparticles (RNPs) [16].
ZBP1 and one of its target mRNAs, β-actin, become
asymmetrically localized to the proximal side of growth
cones when exposed to a polarized netrin-1 gradient
[5,7], and this cue-proximal side shows elevated levels of
β-actin protein synthesis within minutes [5]. Inhibition
of β-actin translation blocks attractive growth cone turn-
ing without affecting extension indicating a key role for
LPS in cue-induced directional steering [5,7].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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translational activation suggest a role for components of
the cellular cytoskeleton in LPS. It is known that long-
range mRNA distribution into axons and dendrites oc-
curs through motor-based transport on microtubule
tracks [17,18], and dispersion into dendrites and den-
dritic spines is thought to be mediated by actin-based
myosin transport [18-20]. Early electron microscope
studies in various non-neuronal cell types show poly-
somes attached to cytoskeletal filaments [21-24].
mRNAs and several factors of the translation machinery
have also been found to associate with the cytoskeleton,
and the degree of this association can be modulated by
physiologically relevant stimuli [25,26]. Thus, it seems
plausible that components of the cytoskeleton may play
critical roles in the rapid, highly localized translational
responses of growth cones to cue-induced stimuli. Sur-
prising, however, this has not yet been tested.
We sought, therefore, to investigate the roles of the
F-actin and microtubule cytoskeleton in guidance cue-
induced translation in the growth cone by disrupting
either F-actin or microtubules while examining netrin-1-
induced LPS. Interestingly, both cytoskeletal elements
are required for LPS, but each one regulates distinct as-
pects of this process: actin microfilaments are needed
for the early signaling steps in a growth cone’s response
to netrin-1 stimulation leading to translation initiation,
whereas microtubules are not required until after the
translation initiation step.Figure 1 The effects of pharmacological inhibitors of actin and micro
Embryonic eyes at stage 24/25 were cultured for 24 h, treated with either c
for F-actin (Phalloidin-Alexa488) or β-tubulin. Control retinal growth cones
rupted upon treatment with (B) cytochalasin D (0.1 μM) and (C) latrunculin
in the growth cone central domain and individual microtubules invading t
cone, but not in the axon shaft, were depolymerized upon treatment with
treatment paradigm of actin or microtubule inhibitors did not affect the ul
also did not increase growth cone collapse at the concentrations used. ScaResults
F-actin and microtubule inhibitors block netrin-1-induced
local protein synthesis
To investigate the role of the growth cone cytoskeleton
in guidance cue-induced translation, F-actin or micro-
tubule dynamics were disrupted in the growth cone
using the pharmacological inhibitors cytochalasin D and
latrunculin B (inhibitors of actin polymerization) and
colchicine and nocodazole (inhibitors of microtubule
polymerization). Since high doses of these drugs can dis-
rupt both cytoskeletal elements, we first conducted
dose-response experiments to determine the lowest dose
of inhibitor that disrupted one cytoskeletal element
without affecting the other. Drug-treated growth cones
were dual-stained using Alexa-fluor-phalloidin (Invitrogen
Life Technologies, Carlsbad, CA, USA) (F-actin) and anti-
β-tubulin and were assessed with fluorescence microscopy
coupled with digital image capture. Our results showed
that 0.1 μM of cytochalasin (or 30 nM latrunculin B)
disrupted the actin cytoskeleton without affecting the
microtubules in the growth cone (Figure 1A, B, C, F, G, H).
Similarly, we found that 12.5 μM of colchicine (or 0.1 μM
nocodazole) left the actin cytoskeleton intact while com-
pletely disrupting growth cone microtubules (Figure 1D,
E, I, J).
We next asked whether these cytoskeletal inhibitors
can affect LPS. To measure LPS, we used a metabolic la-
beling method, the incorporation of L-azidohomoalanine
(AHA). AHA is a methionine analog that can betubule polymerization on retinal growth cone morphology.
ontrol medium or pharmacological inhibitors for 5 min, and stained
(A) contained an extensive network of actin filaments, which was dis-
B (30 nM). Similarly, control retinal growth axons show microtubules
he peripheral domain (F). The dynamic microtubules in the growth
(I) colchicine (12.5 μM) or (J) nocodazole (0.1 μM). Importantly, this
trastructure of the other cytoskeletal system (G and H, D and E) and
le bar 10 μm.
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via click chemistry [27,28], and we used this fluorescent
non-canonical amino acid tagging (FUNCAT) system as a
reporter method to visualize newly synthesized proteins
within growth cones [29]. In cultured stage 24/25 Xenopus
retinal ganglion cell neurons, we found that FUNCAT is a
robust method to detect new protein synthesis, as cells
treated with the protein synthesis inhibitors cycloheximide
and anisomycin displayed near background levels of
FUNCAT signal in comparison to untreated controls
(Figure 2A, G, H). We then performed FUNCAT on
growth cones treated with cytoskeletal inhibitors and
stimulated the cultures with 600 ng/μl netrin-1 forFigure 2 Intact actin and microtubule cytoskeleton are both required
were treated with control medium, cytochalasin D (CytoD), latrunculin B (L
stimulation with either control medium or netrin-1 for a further 5 min. Prot
L-azidohomoalanine (AHA) incorporation and visualized with fluorescent m
medium (A) was markedly increased 5 min following treatment with netrin
with cytochalasin D (C, D) or colchicine (E, F). Protein synthesis within the
cycloheximide (CHX, G) or anisomycin (H). Quantification of fluorescence in
disruption of either actin or microtubule dynamics (I). The number of grow
corresponding bar of the graph in panel I. Similarly, protein synthesis, as m
was stimulated by netrin-1, but this effect was inhibited by treatment with
***P < 0.0001 Mann-Whitney test. Scale bar 10 μm.5 min. Netrin-1 bath application significantly increased
the FUNCAT signal in growth cones, and this increase
was completely blocked by either actin or microtubule
disruption (Figure 2A, B, C, D, E, F, I).
To validate these results, we performed a second
metabolic labeling assay, namely the incorporation of
3H-leucine, on surgically isolated retinal growth cones
[1]. Growth cones severed from their cell bodies were
treated with the cytoskeletal inhibitors followed by con-
current addition of 3H-leucine and netrin-1. Tri-
chloroacetic acid was used to precipitate proteins in situ
on the coverslips, and isotope uptake was measured
with a scintillation counter. Ten minutes of netrin-1for netrin-1-induced protein synthesis. Stage 24/25 retinal explants
B), colchicine (Colc), or nocodazole (Noco) for 5 min, followed by
ein synthesis in growth cones was measured by methionine analog
icroscopy (A-I). Protein synthesis in growth cones treated with control
-1 (B). However, this increase was abolished in growth cones treated
growth cone was almost completely abolished by pretreatment with
tensity reveals that netrin-1-induced protein synthesis is inhibited by
th cones analyzed in each treatment group can be found in the
easured by the incorporation of 3H-leucine in precipitated proteins,
either cytoclalasin D, latrunculin B, colchicine, and nocodazole (J).
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uptake compared to control conditions (Figure 2J and
[1], whereas cells treated with either actin (cytochalasin
D or latrunculin B) or microtubule disrupting drugs
(colchicine or nocodazole) did not show a significant
change in isotope uptake when compared to controls
(Figure 2J). Thus, the integrity of both actin and micro-
tubule cytoskeletal systems is required for the local syn-
thesis of proteins in growth cones.
F-actin, not microtubules, required for early steps in
netrin-1-induced LPS pathway
Protein synthesis is a multistep process that involves the
assembly of dozens of translation machinery compo-
nents [30,31]. Therefore, we next asked which steps of
this process require intact actin and microtubules. The
phosphorylation of the translation initiation factor regu-
lator eIF4E-binding protein 1 (eIF4E-BP1) is a key event
in cap-dependent translation initiation (Figure 3A) [32],Figure 3 Netrin-1-induced increase in eIF4E-BP1 phosphorylation req
schematic of signaling from netrin receptor leading to protein synthesis (A
with the actin depolymerizing agents cytochalasin D (CytoD) and latruncul
(Colc) and nocodazole (Noco) for 5 min, followed by stimulation with either c
translation, retinal cultures were stained for phospho-eIF4E-BP1 (p-eIF4E-BP1;
immunofluorescence signal was measured per unit area (quantified in (C)). Co
significant increase in P-eIF4E-BP1 signal intensity (top row of (B), cytoskeleton
inhibitors (top row of (B), actin-disrupted), but not with microtubule inhibitor
signal intensity is shown in (C). *P< 0.05 Mann-Whitney test. In contrast, levels
affected by netrin-1 or the pharmacological inhibitors. The number of gro
corresponding bar of the graphs in panels (C) and (D). Scale bar 10 μm.and phospho-eIF4E-BP1 immunostaining can be used as
a reporter for translation initiation. Stimulation of retinal
growth cones with the guidance cue netrin-1 has previ-
ously been shown to trigger rapid phosphorylation of
eIF4E-BP1, culminating in LPS [1]. Quantitative im-
munofluorescence (QIF) of growth cones from stage 24/
25 retinal explant cultures showed that phospho-eIF4E-
BP1 levels increased nearly twofold 5 min following
stimulation with netrin-1 (600 ng/ml). When retinal
growth cones were pretreated with cytoskeletal drugs for
5 min, the increase in phospho-eIF4E-BP1 levels was
preserved in colchicine or nocodazole-treated growth
cones but, significantly, it was abolished in growth cones
treated with cytochalasin D and latrunculin B (Figure 3B,
C). These results cannot be explained by a change in the
volume of the growth cone as total eIF4E-BP levels
remained similar under netrin-1-stimulated and drug-
treated conditions (Figure 3D). Thus, translation initiation
in response to netrin-1 stimulation requires an intactuires an intact actin but not microtubule cytoskeleton. A brief
). Stage 24/25 retinal explants were cultured for 24 h, then treated
in (B) (LatB), or the microtubule depolymerizing agents colchicine
ontrol medium or netrin-1 for a further 5 min. To assess the activation of
growth cones in the top row of panel (B)) and the intensity of the
mpared to the control (top row of (B), far left panel) netrin-1 induced a
intact), which was completely blocked upon pretreatment with actin
s (top row of (B), microtubule-disrupted. Quantification of p-eIF4E-BP1
of total eIF4E-BP1 signal intensity (bottom row of (B)) were not significantly
wth cones analyzed in each treatment group can be found in the
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the neuronal growth cone.
The phosphorylation of eIF4E-BP1 depends on target
of rapamycin (mTOR) activation, which itself is down-
stream of the phosphoinositide 3-kinase (PI3K)/Akt sig-
naling pathway [33], which is, in turn, activated in
response to netrin-1 [1,34-36] (Figure 3A). To investi-
gate whether actin is required for netrin-1-induced sig-
naling upstream of eIF4E-BP1 phosphorylation, we
performed immunocytochemistry in neuronal growth
cones to detect active and total forms of specific signal-
ing components in the PI3K/Akt pathway. QIF showed
that upon netrin-1 stimulation, the phosphorylation (ac-
tivation) of mTOR and Akt both required intact actin in
the growth cones, but, as expected, not microtubules
(Figure 4A, B, C, D, E, F, G, H).
Next, we investigated whether PI3K activation also re-
quires the cytoskeleton, and we expressed a live PI3K ac-
tivity reporter, PHAkt-GFP, in retinal ganglion cell
neurons and performed time-lapse imaging of growth
cones in response to bath-applied netrin-1 in the pres-
ence of cytoskeletal drugs. The biosensor PHAkt-GFP
consists of GFP fused to the PIP3-binding PH-domain of
Akt [37]. It binds PIP3 in the plasma membrane where
it is activated by PI3K [36,38,39]. We expressed PHAkt-
GFP in cultured stage 24/25 Xenopus eye primordia and
selected growth cones with low levels of PHAkt-GFP ex-
pression, so that the PH domain did not interfere with
endogenous PI3K signaling [40]. Growth cones were im-
aged at 5-s intervals throughout the following treatment:
2 min of control imaging medium (with 0.1% BSA),
5 min of cytoskeletal drug (DMSO control, 0.1 μM cyto-
chalasin D or 12.5 μM colchicine), 15 min of netrin-1
bath (600 ng/ml, in the presence of cytoskeletal drug).
Background-subtracted fluorescence intensity measure-
ments taken from tracings of the thin growth cone per-
ipheral domain (filopodial and lamellipodial regions;
[41]) were normalized to t = 0 in control-treated growth
cones. We were able to detect a mild but steady increase
in PHAkt-GFP signal in control growth cones stimulated
with netrin-1, which also occurred in microtubule-
disrupted growth cones. However, throughout the dur-
ation of cytochalasin D treatment, growth cones showed
a decline of PHAkt-GFP fluorescence intensity, despite
netrin-1 stimulation (Figure 4I, J), indicative of actin
cytoskeletal integrity being required for PI3K activation
in response to netrin-1 stimulation.
Thus, we have shown that the actin cytoskeleton is re-
quired for the activation of the early steps in the guid-
ance receptor-mediated translation cascade, starting
with PI3K/Akt and then mTOR and eIF4E-BP1. The
microtubule cytoskeleton is not necessary for these early
steps but is required for LPS, raising the question of
where it acts in the translation pathway.Microtubules are involved in polypeptide chain
elongation or translation arrest
Translation occurs in three phases: initiation, elongation,
and termination. Initiation is the most common step of
translation regulation, when the ribosome is recruited to
the mRNA, but the polypeptide chain elongation step
can also serve as a point of regulation. Since microtu-
bules are not required for translation initiation (no effect
on eIF4E-BP1 phosphorylation), we asked whether they
regulate the remaining steps, such as phosphorylation of
eukaryotic elongation factor 2 (eEF2) by eEF2 kinase
(eEF2K) [42] which is downstream of the mTOR protein
complex mTORC1 [43]. In whole mammalian cells and
tissues, eEF2K phosphorylates and inactivates eEF2 lead-
ing to an arrest in mRNA translation [44-46], yet in den-
drites, activation of eEF2K is associated with increased
synthesis of specific proteins [47-51]. We therefore
assessed the activation of eEF2K in growth cones using
QIF with an anti-phospho-EF2K antibody (ser366).
Growth cones in basal conditions (no netrin-1) exhibited
a positive phospho-EF2K signal that was significantly re-
duced following inhibition of mTOR activity with rapa-
mycin (Figure 5A, B, C), consistent with previous studies
showing mTORC1-sensitive eEF2K activation [52].
Stimulation with netrin-1 for 5 min elicited a significant
increase in both phospho-eEF2K and phospho-eEF2 sig-
nals in growth cones, and these increases were pre-
vented by treatment with colchicine (Figure 5D, E).
Cytochalasin D treatment also inhibited activation of
both eEF2K and eEF2 (data not shown), although this is
not surprising given that F-actin is needed for the up-
stream steps of the pathway (as shown above). The pos-
sibility that the F-actin cytoskeleton is also involved in
regulating eEF2K, however, cannot be eliminated. Thus,
our results show that the activation of the eEF2K/eEF2
pathway is dependent on microtubules (and possibly
F-actin) but leave open the determination of whether
increased polypeptide elongation or the prevention of
its arrest requires microtubule function.
Microtubule disruption depletes RNP granules from the
growth cone periphery
Since mRNAs are actively transported into distal axons
on microtubules via motor proteins [17,53,54], we hy-
pothesized that microtubules might also be required for
RNP trafficking into the growth cone periphery, in
addition to their role in facilitating polypeptide elong-
ation. To investigate this, we labeled ribonucleoprotein
(RNP)-containing granules in Xenopus retinal ganglion
cells by injecting fluorescently conjugated uridine triphos-
phate (Cy3-UTP) analogs into dorsal blastomeres of four-
to eight-cell stage embryos. Eye primordia of stage 24/25
embryos were cultured on coverslips, and growth cones
containing Cy3-UTP-labeled granules were imaged before
Figure 4 Actin, but not microtubule, disruption blocks netrin-1 induced PI3K/Akt/mTOR signaling in growth cones. Cultured stage 24/25
retinal explants were treated with a DMSO vehicle control, cytochalasin D (CytD), or colchicine (Colc) for 5 min, followed by 5-min stimulation
with either control medium or netrin-1. Quantitative immunofluorescence showed that levels of activated mTOR (p-mTOR; (A)) and Akt (p-Akt;
(E)) were elevated by netrin-1 stimulation, a process that was prevented by actin, but not microtubule disruption (quantified in (C) and (G)). Total
levels of mTOR (B) and Akt (F) were not significantly altered following stimulation with netrin-1, in either untreated or growth cones treated with
cytoskeletal disrupting agents (quantified in (D) and (H)), with the exception of total Akt levels in growth cones treated with colchicine, which
showed a small, but significant increase in fluorescence intensity. The number of growth cones analyzed in each treatment group can be found
in the corresponding bar of the respective graphs. **P < 0.005; ***P < 0.0001 Mann-Whitney test. (I) Pseudocolored images of a live PI3K biosensor
(PHAkt-GFP) before and after netrin-1 stimulation in the presence of cytoskeletal inhibitors. Growth cones expressing low levels of PHAkt-GFP
were treated with cytoskeletal inhibitors (0.1 μM cytochalasin D or 12.5 μM colchicine) on stage during time-lapse acquisition on an inverted
spinning disk confocal system (60× water immersion). Time-lapse imaging showed an increase in PHAkt-GFP signal after netrin-1 stimulation,
which was inhibited by cytochalasin D treatment, but not affected by colchicine treatment (J). Background-subtracted fluorescent signals were
normalized to the control medium at time 0. Scale bar 10 μm.
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Figure 5 Microtubule depolymerization inhibits netrin-1 induced phosphorylation of EF2K and EF2. Cultured stage 24/25 retinal explants
were treated with the mTOR inhibitor rapamycin or a vehicle only control (A, B). Rapamycin induced a significant reduction in the level of
phosphorylation of a downstream target of mTOR, eEF2 kinase (A-C). Quantitative immunofluorescence was also used to assess the levels of
phosphorylation of both eEF2 kinase (D) and eEF2 (E) in response to netrin-1 stimulation. Netrin-1 induced a significant increase in the
fluorescence intensity of both phospho-eEF2 kinase (D) and phospho-eEF2 (E) in growth cones treated with a DMSO vehicle control (ctrl).
However, no significant changes in fluorescence intensity following netrin-1 stimulation were observed following inhibition of the microtubule
cytoskeleton with colchicine (colc; (D, E)). The number of growth cones analyzed in each treatment group can be found in the corresponding bar of
the respective graphs. ns = not significant. ***P < 0.0005 Mann-Whitney test. Scale bar 10 μm.
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B). Time-lapse imaging revealed that the Cy3-UTP-
positive RNP granules were highly dynamic in the axon
moving anterogradely and retrogradely. In the growth
cone, Cy3-UTP-positive RNP granules accumulated pri-
marily in the central domain and individual granules com-
monly made excursions into lamellipodia and filopodia in
the growth cone periphery before cytoskeletal drug treat-
ment (Figure 6A, B, top panels, arrowhead; Movie 1). This
dynamic movement of RNP granules into the periphery
was greatly reduced in growth cones treated with colchi-
cine (Figure 6A, lower panel, 8 growth cones from a total
of 10 growth cones exhibited a reduction in the movement
of RNP granules into the periphery; Additional files 1
and 2) yet persisted in cytochalasin D-treated cells
(Figure 6B lower panel, arrowhead, 8 growth cones
from a total of 11 growth cones exhibited continued
movement of RNP granules into the periphery; Additional
files 3 and 4). The number of RNP granules from −5 to
0 min (before drug addition) and 5 to 10 min after drug
addition in the growth cone periphery was also assessedby counting the number of RNP granules in the growth
cone periphery at 1-min intervals. The average number of
peripherally located granules per colchicine-treated
growth cone was 10.5 ± 2.4 and 1.4 ± 0.3 5 min before and
5 min after drug treatment, respectively. On the other
hand, the number of peripherally located RNP granules in
cytochalasin D-treated growth cones was 9.5 ± 2.2 and
10.2 ± 2.3, before and after drug treatment, respectively.
We conclude that dynamic microtubules, but not actin,
are required for delivery of RNP granules to the growth
cone periphery. Colchicine, by blocking the netrin-1-
induced re-localization of RNPs into the growth cone filo-
podia/lamellipodia [5], could reduce the availability of a
population of mRNAs to activated ribosomal machinery
in the periphery and thereby reduce translation.
Discussion
Guidance cue-induced protein synthesis in the growth
cone plays a role in acute steering responses, such as turn-
ing, and many of the locally translated proteins are in-
volved in growth cone motility [4,5,7,55]. Genome-wide
Figure 6 Inhibition of dynamic microtubules prevents RNP granule movement into the growth cone periphery. Embryos were injected
with fluorescently labeled UTP (Cy3-UTP) at the four to eight-cell stage to visualize ribonucleoprotein (RNP) granules. Cultured stage 24/25 retinal
explants positive for Cy3-UTP-labeled RNP granules were selected for time-lapse imaging on an inverted spinning disk confocal system (60× water
immersion objective, 5-s acquisition interval) and treated on-stage with cytoskeletal disrupting drugs. Prior to colchicine treatment, RNP granules
were trafficked to the growth cone periphery (arrowheads, top row in (A)). However, colchicine treatment acutely blocked RNP granule movement
into the peripheral domain (bottom row in (A), 8 out of 10 growth cones). In contrast, cytochalasin D treatment did not affect RNP granule trafficking
to the periphery (arrowheads in bottom row of (B), 8 out of 11 growth cones). Representative frames per minute from before and 5 min
after colchicine (panels in A) or cytochalasin D (panels in B) treatment are shown. Numbers in the lower left of each image represent time
in minutes.
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mRNAs of several cytoskeletal components and their reg-
ulators are present and locally translated in growth cones
in response to guidance cues, but as the cytoskeleton may
itself regulate translation [56], we investigated the poten-
tial roles of the two major growth cone cytoskeletal sys-
tems, F-actin and microtubules, in the control of cue-
induced LPS in growth cones. We found that both cyto-
skeletal systems are essential for cue-induced LPS but that
they are involved at different stages in the translation
process. An intact actin cytoskeleton is required for
netrin-1-induced activation of translation initiation while
microtubules are needed for polypeptide chain elongation
and the delivery of RNPs to their correct target sites.
In line with previous studies showing a requirement
for the actin cytoskeleton in translation [57,58], our find-
ings demonstrate that an intact F-actin network iscrucial for LPS in axonal growth cones in response to at-
tractive guidance cues such as netrin-1. Indeed, our re-
sults reveal that proper actin dynamics are required at
least as early as PI3K/Akt activation after netrin-1
stimulation. The resolution of the spinning disk confocal
was not sufficient to allow us to determine whether the
PHAkt-GFP biosensor was associated with the cellular
membrane. However, the fact that this is the known site
of Akt activation suggests that the decline in the biosen-
sor (PHAkt-GFP) signal in the netrin-1 stimulated
growth cones in the presence of cytochalasin D was due
either to the failure of the reporter or its activators to
translocate to the membrane [59]. Our results are also
consistent with findings that implicate the F-actin cyto-
skeleton in the control of several aspects of translational
control, such as translation initiation and anchoring of
the elongation factor 1α to the F-actin network [57,60].
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require the integrity of the F-actin network in models as
diverse as yeast [57] and goldfish Mauthner axons [58].
Accumulating evidence implicates the F-actin network
as a platform on which translation initiation is regulated
[61]. Using both morphological and biochemical tech-
niques, mRNAs, polysomes, and translational machinery
have been localized to the cytoskeleton [62]. More re-
cently, the F-actin-binding protein Short stop (Shot) and
Krasavietz, a Shot binding partner, have been shown to
provide a direct link between cytoskeletal reorganization
and translation regulation in midline crossing of com-
missural neurons in the Drosophila nerve cord [63].
These findings suggest that the F-actin cytoskeleton acts
as a coordinating center, enabling the rapid transmission
of signals from activated guidance receptors to the trans-
lational machinery and hence facilitating the rapid local
protein synthesis initiated by guidance cues such as
netrin-1 [5]. Although it is not possible from these ex-
periments to determine specifically where F-actin is
needed, as it is required from the earliest stages down-
stream of receptor activation, it seems likely that the F-
actin network will be required at multiple levels of this
hierarchy, due to the localization of many components
of the translational machinery to the actin network.
Our findings show that intact microtubules are also
essential for axonal LPS. However, although F-actin
and microtubules together coordinately regulate axon
extension/retraction, our results reveal that the early
steps of translation (eIF4E-BP1 activation) occur in the
absence of intact microtubule cytoskeleton. What role,
then, do microtubules play in this process? Previous
work has shown that mRNAs are actively transported
into the distal axon on microtubules via motor proteins
[17,53,54,64]. Furthermore, in neurons, poly(A) mRNA
binds to microtubules and ribosomes and several
elongation factors are associated with microtubule
cytoskeleton [64-68] indicating that microtubules play
a role in tethering the translational machinery and po-
tentially regulating translation. In line with these previ-
ous studies, our time-lapse imaging results show that
RNA trafficking in the growth cone, particularly into
the peripheral regions, depends on microtubules and
not F-actin. However, since availability of mRNAs is a
prerequisite for translation initiation, how can we ex-
plain the fact that colchicine did not block netrin-1-
induced eIF4E-BP1 phosphorylation? One possibility is
that a small population of mRNAs is actively trans-
ported to the growth cone upon netrin-1 stimulation
but that other mRNAs are already present in the per-
iphery. As colchicine does not remove existing mRNAs,
the netrin-1 stimulus may be sufficient to initiate the
translation machinery on these mRNAs, explaining the
persisting phospho-eIF4E-BP signal in such treatments.Our results show that an intact microtubule cytoskel-
eton is needed for netrin-1’s activation of eEF2K impli-
cating a role in regulating the elongation or arrest steps
of translation. Classically, eEF2K phosphorylates and in-
activates eEF2 leading to an arrest in mRNA translation
[44-46]. However, we found that 5 min of netrin-1
stimulation triggers an increase in both protein synthesis
and eEF2K activation in axonal growth cones. This result
is more in line with recent work in dendrites where
eEF2K is activated by glutamate signaling through both
NMDA and glutamate metabotropic receptors [47,48].
In this system, the translation rate of specific mRNAs in-
volved in synapse function such as Arc, MAP1B, and
alphaCaMKII, is upregulated [49-51]. This raises the in-
triguing idea that activation of the eEF2k/eEF2 pathway
by netrin-1 may repress global translation while at the
same time upregulating translation in specific subcellular
compartments such as dendrites and growth cones
where select mRNAs such as β-actin, GAP43, and Arc
play highly localized roles in growth, guidance, and syn-
aptic function.
In the context of axon guidance, actin pharmacological
inhibitors cause axon pathfinding errors in vivo [69,70].
Since cytochalasin treatment leads to the loss of the
actin-rich filopodia from growth cones, these studies
concluded that filopodia are necessary for accurate path-
finding [69,70]. Puzzlingly, however, growth cones can
pathfind normally when their filopodia are eliminated by
Ena/VASP depletion rather than by cytochalasin [71].
Our current findings offer a possible explanation for
these apparently discrepant findings in terms of axonal
translation. Ena/VASP depletion should not affect the in-
tegrity of the F-actin cytoskeleton, only its polymerization.
Thus, in addition to essential roles, it plays in growth cone
motility and structure, F-actin also provides an essential
platform for LPS allowing the spatial regulation of the
local proteome in subcellular space, which may be im-
portant for cue-induced turning [5]. Our data on the
role of actin in the initiation of translation due to
netrin-1 signaling is interesting in light of the results of
Tcherkezian et al. [29], who found that DCC, the netrin
receptor, controls translation of axonally localized mRNAs
by directly interacting with translation initiation factors as
well as ribosomal proteins. If, as this model suggests, DCC
acts as a platform for the assembly of translation regula-
tors, disruption of the cytoskeleton may interfere with the
translocation of these factors to this platform.
Conclusions
In summary, we have shown that both an intact actin
and microtubule cytoskeleton are essential for cue-
induced LPS, but that the two elements have distinct
roles in this process. Only disruption of actin blocks the
early steps in translation initiation. In both cases, there
Piper et al. Neural Development  (2015) 10:3 Page 10 of 13is still much to learn about the molecular nature of these
dynamic interactions, which particular steps are affected,
and how exactly these are regulated by the different
cytoskeletal components. Further dissection of the rela-
tion between cytoskeletal elements and translation ma-
chinery may help explain the logistics of translation
control in axon navigation.
Methods
Primary culture of Xenopus retinal explants
Oocytes obtained from adult wild-type female Xenopus
laevis injected with human chorionic gonadotropin hor-
mone (Sigma-Aldrich Corporation, St. Louis, MO, USA)
were fertilized in vitro, then raised at 14°C to 18°C in
0.1× modified Barth’s saline (MBS). Embryos were staged
according to the tables of Nieuwkoop and Faber. Eye
primordia from stage 24/25 embryos were dissected and
cultured on acid-cleaned 12-mm round glass coverslips
coated with 10 μg/ml poly-L-lysine (Sigma-Aldrich
Corporation, St. Louis, MO, USA) and 1 μg/ml fibro-
nectin (Calbiochem-Novabiochem Corp., La Jolla, CA,
USA). Cultures were kept in 60% L15 medium (Invitrogen
Life Technologies, Carlsbad, CA, USA) supplemented
with Pen/Strep/Fungizone (Invitrogen Life Technologies,
Carlsbad, CA, USA, 1:100) for 24 h at 20°C before experi-
mentation. All animal experiments were approved by the
Ethical Review Committee of the University of Cambridge
and complied with Home Office guidelines.
Pharmacological agents
The following pharmacological agents were bath applied
to retinal cultures for 5 min to interfere with actin and
microtubule dynamics: 0.1 μM cytochalasin D (Sigma-
Aldrich Corporation, St. Louis, MO, USA), 30 nM latrun-
culin B (Sigma-Aldrich Corporation, St. Louis, MO, USA),
12.5 μM colchicine (Sigma-Aldrich Corporation, St. Louis,
MO, USA), and 0.1 μM nocodazole (Sigma-Aldrich
Corporation, St. Louis, MO, USA). Cycloheximide
(100 μg/ml) (Sigma-Aldrich Corporation, St. Louis, MO,
USA) and 40 μM anisomycin (Sigma-Aldrich Corporation,
St. Louis, MO, USA) were used to block protein syn-
thesis. DMSO (0.1%) (vehicle) was included in control
conditions.
Antibodies
Phosphorylated and total forms of proteins were de-
tected by immunocytochemistry using antibodies from
the following companies: anti-phospho-eIF4E-BP1 (Ser65)
(1:100), anti-eIF4E-BP1 (1:100), anti-mTOR (1:100), anti-
phospho-Akt (Ser473) (1:250), anti-Akt (1:250), anti-
phospho-eEF2 (Thr 56) (1:100), anti-eEF2 kinase (1:100),
and anti-phospho-eEF2 kinase (Ser366) from Cell Signaling
Technology, Danvers, MA, USA; anti-phospho-mTOR
(S2448) (1:250) from Abcam, Cambridge, MA, USA; andanti-EF2 (C-14) (1:100) from Santa Cruz Biotechnology,
Santa Cruz, CA, USA. F-actin was visualized with
Alexa-Fluor 594-phalloidin (used at 1:50; Invitrogen
Life Technologies, Carlsbad, CA, USA), and β-tubulin
was labeled with anti-β-tubulin (used at 1:1000; Sigma-
Aldrich Corporation, St. Louis, MO, USA). Secondary
antibodies conjugated with Alexa Fluor dyes were from
Invitrogen Life Technologies, Carlsbad, CA, USA.
Immunofluorescence and image acquisition
Twenty-four-hour cultures of stage 24/25 retinal ex-
plants were incubated with cytoskeletal inhibitors for
5 min, followed by 5 min of netrin-1 (600 ng/ml, mouse
recombinant, R&D Systems, Minneapolis, MN, USA) or
control medium containing netrin-1 carrier 0.1% bovine
serum albumin (BSA; Sigma-Aldrich Corporation, St.
Louis, MO, USA). Cultures were fixed in 2% paraformal-
dehyde/7.5% sucrose for 30 min, permeabilized with
0.1% saponin (Sigma-Aldrich Corporation, St. Louis,
MO, USA), and blocked with 5% goat serum. The cul-
tures were then labeled with primary antibodies for 1 h,
followed by 30 min of secondary antibody incubation
(Alexa Fluor-conjugated, Invitrogen Life Technologies,
Carlsbad, CA, USA, 1:500), and mounted in FluorSave
(Calbiochem-Novabiochem Corp., La Jolla, CA, USA).
Non-collapsed growth cones were visualized with a 60×
1.4 NA oil objective on a Nikon Eclipse inverted micro-
scope (Nikon, Tokyo, Japan). Using phase optics to avoid
biased selection of fluorescence, individual growth cones
were randomly selected and imaged using a Hamamatsu
digital CCD camera (Hamamatsu Photonics, Hamamatsu,
Japan). A fluorescent image was then captured, exposure time
being kept constant and below greyscale pixel saturation.
Quantification of fluorescence intensity
For quantification of fluorescence intensity, the growth
cone outline was traced on the phase image by using
Openlab software (Improvision, Lexington, MA, USA)
and then superimposed on the fluorescent image. The
software calculated the fluorescent intensity within the
growth cone, giving a measurement of pixel intensity per
unit area. The growth cone outline was then placed in
an adjacent area clear of cellular material to record the
background fluorescent intensity. This reading was sub-
tracted from the growth cone reading, yielding the
background-corrected intensity. The fluorescent inten-
sities of between 25 and 60 growth cones per sample
group in each experiment were collected. Data were nor-
malized against the control-treated group to allow for
comparisons between experiments and are presented as
percentage of control fluorescent intensity. Error bars
represent SEM. Samples from independent experiments
were stained, imaged, and processed under identical
conditions. Counts in which the experimenter was blind
Piper et al. Neural Development  (2015) 10:3 Page 11 of 13to the identity of the samples resulted in similar results.
Statistical analysis was performed using a two-tailed
Mann-Whitney test.
Protein synthesis metabolic assays
To measure protein synthesis in isolated growth cones,
the metabolic assays 3H-leucine incorporation and AHA
protein synthesis fluorescence microscopy were per-
formed. 3H-leucine incorporation assays were performed
as described previously [53]. Briefly, stage 35/36 retinal
explants containing retinal ganglion cell bodies were re-
moved from the neurites with a razor. Coverslips with
attached neurites were moved to leucine-free medium,
and pharmacological inhibitors were added 5 min before
the addition of control medium or netrin-1, immediately
followed by the addition of L-[4,5-3H]leucine (5.66 TBq/
mmol; Amersham). Cultures were then rinsed and fixed
in 25% tri-chloroacetic acid, and 3H uptake was mea-
sured with a scintillation counter. We performed this ex-
periment on four independent occasions, and within
each trial, experiments were performed in duplicate. The
AHA assay was performed following instructions from
the Click-iT AHA Alexa Fluor 488 Protein Synthesis
HCS Assay kit (Invitrogen Life Technologies, Carlsbad,
CA, USA, C10289), which detects incorporated methio-
nine analog AHA with an Alexa Fluor 488 alkyne using
Click chemistry [18]. Culture medium was replaced with
methionine-free medium followed by 20 min of 100-μM
AHA reagent incubation. Cytoskeletal inhibitor was ap-
plied for 5 min, followed by 5 min of netrin-1 (600 ng/ml)
or control (0.1% BSA). The cells were then fixed with 2%
paraformaldehyde/7.5% sucrose and permeabilized with
0.1% Triton-X-100. Click-iT reaction mix was added to
the cultures for 30 min, and samples were mounted using
FluorSave mounting medium (Calbiochem-Novabiochem
Corp., La Jolla, CA, USA) after a final wash.
Live cell imaging in Xenopus retinal ganglion neuron
growth cones
For live cell imaging of PI3K activity, Xenopus embryos
were injected at the four- to eight-cell stage in dorsal
blastomeres with 125 pg of DNA encoding PHAkt-GFP
biosensor (Addgene plasmid 18836, kindly deposited by
Dr. Craig Montell [72]) per blastomere. For labeling
RNP granules, four- to eight-cell stage embryos were
injected with 10 nl of 100 μM Cyanine 3-UTP (Perkin
Elmer, Waltham, MA, USA). In order to co-image RNP
granules with microtubules, some embryos were co-
injected with 100 pg per blastomere of DNA encoding
tubulin-EGFP (pEGFP vector, Clonetech, Palo Alto, CA,
USA). Stage 24/25 embryos with positive fluorescence la-
beling in the eye primordia were selected for culture on
glass bottom imaging dishes (MatTek). Culture medium
was replaced with imaging medium (60% Phenol Red-freeL15 medium supplemented with 1 mg/ml BSA, 1 mg/
ml L-carnosine, and 25 mM vitamin E; chemicals from
Sigma-Aldrich Corporation, St. Louis, MO, USA or
Calbiochem-Novabiochem Corp., La Jolla, CA, USA)
1 h before microscopy. Label-positive growth cones
were imaged on an inverted spinning disk confocal sys-
tem (Perkin Elmer UltraVIEW ERS, Waltham, MA,
USA) using a 60× 1.2 NA water immersion objective at
room temperature (23°C). Time-lapse images were
taken for 5 min before and after cytoskeletal drug ap-
plication and continued for 10 to 15 min after netrin-1
bath stimulus at 5-s acquisition intervals using Volocity
software (Perkin Elmer, Waltham, MA, USA). Fluores-
cence intensity analysis was done in ImageJ software
(NIH), and intensity map figures were generated with
MATLAB 7.14 (release R2012a, Mathworks).Additional files
Additional file 1: Inhibition of dynamic microtubules prevents RNP
granule movement into the growth cone periphery. Movie revealing
that inhibition of dynamic microtubules inhibits the movement of RNP
granules to the growth cone periphery. Embryos were injected with
fluorescently labeled UTP (Cy3-UTP) at the four to eight-cell stage to
visualize ribonucleoprotein (RNP) granules. Cultured stage 24/25 retinal
explants positive for Cy3-UTP-labeled RNP granules were selected for
time-lapse imaging on an inverted spinning disk confocal system (60×
water immersion objective, 5-s acquisition interval) and treated on-stage
with the microtubule disrupting drug colchicine (colch). Prior to colchicine
treatment, RNP granules were trafficked to the growth cone periphery.
However, colchicine treatment acutely blocked RNP granule movement
into the peripheral growth cone domain. The corresponding differential
interference contrast (DIC) images for this time-lapse sequence is
provided in Additional file 2.
Additional file 2: Inhibition of dynamic microtubules prevents RNP
granule movement into the growth cone periphery. Differential
interference contrast imaging of the growth cone shown in Additional
file 1, revealing that this growth cone does possess cytoplasmic
extensions following treatment with colchicine, suggesting that the loss
of RNP granule movement to the growth cone periphery following
microtubule disruption is not due to the loss of these processes.
Additional file 2 is taken with differential interference contrast (DIC)
optics (5-s acquisition interval).
Additional file 3: Inhibition of the actin cytoskeleton does not
prevent RNP granule movement into the growth cone periphery.
Movie revealing that inhibition the actin cytoskeleton does not inhibit
the movement of RNP granules to the growth cone periphery. Embryos
were injected with fluorescently labeled UTP (Cy3-UTP) at the four to
eight-cell stage to visualize ribonucleoprotein (RNP) granules. Cultured
stage 24/25 retinal explants positive for Cy3-UTP-labeled RNP granules
were selected for time-lapse imaging on an inverted spinning disk
confocal system (60× water immersion objective, 5-s acquisition interval)
and treated on-stage with the actin disrupting drug cytochalasin D. Prior
to colchicine treatment, RNP granules were trafficked to the growth cone
periphery, a process that continued following cytochalasin D treatment.
The corresponding differential interference contrast images for this
time-lapse sequence is provided in Additional file 4.
Additional file 4: Inhibition of the actin cytoskeleton does not
prevent RNP granule movement into the growth cone periphery.
Differential interference contrast imaging of the growth cone shown in
Additional file 3, revealing that this growth cone possesses cytoplasmic
extensions following treatment with cytochalasin D. Additional file 4 is taken
with differential interference contrast (DIC) optics (5-s acquisition interval).
Piper et al. Neural Development  (2015) 10:3 Page 12 of 13Abbreviations
3′ UTR: 3′ untranslated region; AHA: L-azidohomoalanine; eEF2: eukaryotic
elongation factor 2; eEF2K: eEF2 kinase; eIF4E-BP1: translation initiation factor
regulator eIF4E-binding protein 1; FUNCAT: fluorescent non-canonical amino
acid tagging; LPS: local protein synthesis; mTOR: target of rapamycin;
PI3K: phosphoinositide 3-kinase; QIF: quantitative immunofluorescence;
RGC: retinal ganglion cell; RNP: ribonucleoparticle; ZBP: zipcode binding
protein 1.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MP carried out the 3H-leucine incorporation assays, participated in the QIF
studies, and drafted the manuscript. ACL performed the AHA and the
FUNCAT experiments, participated in the QIF studies, and helped to draft the
manuscript. FvH, HM, and TBL participated in the QIF studies. WAH and CEH
conceived of the study and participated in its design and coordination and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was funded by EMBO Long Term Fellowships (ACL and FvH) and a
Wellcome Trust Programme Grant (CEH; grant 085314/Z/08/Z).
Author details
1Department of Physiology, Development and Neuroscience, University of
Cambridge, Downing street, Cambridge CB2 3DY, UK. 2Current address: The
School of Biomedical Sciences and the Queensland Brain Institute, The
University of Queensland, St Lucia, QLD 4072, Australia. 3Current address:
Institute of Neuroscience, Chinese Academy of Sciences, Shanghai 200031,
China.
Received: 22 November 2014 Accepted: 4 February 2015
References
1. Campbell DS, Holt CE. Chemotropic responses of retinal growth cones
mediated by rapid local protein synthesis and degradation. Neuron.
2001;32:1013–26.
2. Guirland C, Buck KB, Gibney JA, DiCicco-Bloom E, Zheng JQ. Direct cAMP
signaling through G-protein-coupled receptors mediates growth cone
attraction induced by pituitary adenylate cyclase-activating polypeptide. J
Neurosci. 2003;23:2274–83.
3. Brunet I, Weinl C, Piper M, Trembleau A, Volovitch M, Harris W, et al. The
transcription factor Engrailed-2 guides retinal axons. Nature. 2005;438:94–8.
4. Wu KY, Hengst U, Cox LJ, Macosko EZ, Jeromin A, Urquhart ER, et al. Local
translation of RhoA regulates growth cone collapse. Nature.
2005;436:1020–4.
5. Leung KM, van Horck FP, Lin AC, Allison R, Standart N, Holt CE.
Asymmetrical beta-actin mRNA translation in growth cones mediates
attractive turning to netrin-1. Nat Neurosci. 2006;9:1247–56.
6. Piper M, Anderson R, Dwivedy A, Weinl C, van Horck F, Leung KM, et al.
Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal
growth cones. Neuron. 2006;49:215–28.
7. Yao J, Sasaki Y, Wen Z, Bassell GJ, Zheng JQ. An essential role for beta-actin
mRNA localization and translation in Ca2 + -dependent growth cone
guidance. Nat Neurosci. 2006;9:1265–73.
8. Manns RP, Cook GM, Holt CE, Keynes RJ. Differing semaphorin 3A
concentrations trigger distinct signaling mechanisms in growth cone
collapse. J Neurosci. 2012;32:8554–9.
9. Nedelec S, Peljto M, Shi P, Amoroso MW, Kam LC, Wichterle H.
Concentration-dependent requirement for local protein synthesis in motor
neuron subtype-specific response to axon guidance cues. J Neurosci.
2012;32:1496–506.
10. Ming GL, Wong ST, Henley J, Yuan XB, Song HJ, Spitzer NC, et al.
Adaptation in the chemotactic guidance of nerve growth cones. Nature.
2002;417:411–8.
11. Piper M, Salih S, Weinl C, Holt CE, Harris WA. Endocytosis-dependent
desensitization and protein synthesis-dependent resensitization in retinal
growth cone adaptation. Nat Neurosci. 2005;8:179–86.12. Brittis PA, Lu Q, Flanagan JG. Axonal protein synthesis provides a
mechanism for localized regulation at an intermediate target. Cell.
2002;110:223–35.
13. Thelen K, Maier B, Faber M, Albrecht C, Fischer P, Pollerberg GE. Translation
of the cell adhesion molecule ALCAM in axonal growth cones - regulation
and functional importance. J Cell Sci. 2012;125:1003–14.
14. Colak D, Ji SJ, Porse BT, Jaffrey SR. Regulation of axon guidance by
compartmentalized nonsense-mediated mRNA decay. Cell.
2013;153:1252–65.
15. Leung LC, Urbancic V, Baudet ML, Dwivedy A, Bayley TG, Lee AC, et al.
Coupling of NF-protocadherin signaling to axon guidance by cue-induced
translation. Nat Neurosci. 2013;16:166–73.
16. Kiebler MA, Bassell GJ. Neuronal RNA granules: movers and makers. Neuron.
2006;51:685–90.
17. Hirokawa N. mRNA transport in dendrites: RNA granules, motors, and tracks.
J Neurosci. 2006;26:7139–42.
18. Xing L, Bassell GJ. mRNA localization: an orchestration of assembly, traffic
and synthesis. Traffic. 2013;14:2–14.
19. Yoshimura A, Fujii R, Watanabe Y, Okabe S, Fukui K, Takumi T. Myosin-Va
facilitates the accumulation of mRNA/protein complex in dendritic spines.
Curr Biol. 2006;16:2345–51.
20. Bramham CR, Wells DG. Dendritic mRNA: transport, translation and function.
Nat Rev Neurosci. 2007;8:776–89.
21. Lenk R, Ransom L, Kaufmann Y, Penman S. A cytoskeletal structure with
associated polyribosomes obtained from HeLa cells. Cell. 1977;10:67–78.
22. Wolosewick JJ, Porter KR. Observation on the morphological heterogeneity
of WI-38 cells. Am J Anat. 1977;149:197–225.
23. Fulton AB, Wan KM, Penman S. The spatial distribution of polyribosomes in
3 T3 cells and the associated assembly of proteins into the skeletal
framework. Cell. 1980;20:849–57.
24. Ramaekers FC, Benedetti EL, Dunia I, Vorstenbosch P, Bloemendal H.
Polyribosomes associated with microfilaments in cultured lens cells. Biochim
Biophys Acta. 1983;740:441–8.
25. Hesketh JE, Pryme IF. Evidence that insulin increases the proportion of
polysomes that are bound to the cytoskeleton in 3 T3 fibroblasts. FEBS Lett.
1988;231:62–6.
26. Hesketh JE, Pryme IF. Interaction between mRNA, ribosomes and the
cytoskeleton. Biochem J. 1991;277(Pt 1):1–10.
27. Dieterich DC, Lee JJ, Link AJ, Graumann J, Tirrell DA, Schuman EM. Labeling,
detection and identification of newly synthesized proteomes with
bioorthogonal non-canonical amino-acid tagging. Nat Protoc.
2007;2:532–40.
28. Dieterich DC, Hodas JJ, Gouzer G, Shadrin IY, Ngo JT, Triller A, et al. In situ
visualization and dynamics of newly synthesized proteins in rat
hippocampal neurons. Nat Neurosci. 2010;13:897–905.
29. Tcherkezian J, Brittis PA, Thomas F, Roux PP, Flanagan JG. Transmembrane
receptor DCC associates with protein synthesis machinery and regulates
translation. Cell. 2010;141:632–44.
30. Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat
Rev Mol Cell Biol. 2004;5:827–35.
31. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation
initiation and principles of its regulation. Nat Rev Mol Cell Biol.
2010;11:113–27.
32. Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E
inhibitory proteins. Nature. 2005;433:477–80.
33. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF,
et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.
Genes Dev. 1999;13:1422–37.
34. Ming G, Song H, Berninger B, Inagaki N, Tessier-Lavigne M, Poo M. Phospholipase
C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signaling in nerve
growth cone guidance. Neuron. 1999;23:139–48.
35. Chang C, Adler CE, Krause M, Clark SG, Gertler FB, Tessier-Lavigne M, et al.
MIG-10/lamellipodin and AGE-1/PI3K promote axon guidance and outgrowth
in response to slit and netrin. Curr Biol. 2006;16:854–62.
36. Henle SJ, Wang G, Liang E, Wu M, Poo MM, Henley JR. Asymmetric PI(3,4,5)
P3 and Akt signaling mediates chemotaxis of axonal growth cones. J
Neurosci. 2011;31:7016–27.
37. Varnai P, Balla T. Visualization of phosphoinositides that bind pleckstrin
homology domains: calcium- and agonist-induced dynamic changes and
relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol.
1998;143:501–10.
Piper et al. Neural Development  (2015) 10:3 Page 13 of 1338. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR.
Polarization of chemoattractant receptor signaling during neutrophil
chemotaxis. Science. 2000;287:1037–40.
39. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. Lipid
products of PI(3)Ks maintain persistent cell polarity and directed motility in
neutrophils. Nat Cell Biol. 2002;4:513–8.
40. Akiyama H, Kamiguchi H. Phosphatidylinositol 3-kinase facilitates
microtubule-dependent membrane transport for neuronal growth cone
guidance. J Biol Chem. 2010;285:41740–8.
41. Bridgman PC, Dailey ME. The organization of myosin and actin in rapid
frozen nerve growth cones. J Cell Biol. 1989;108:95–109.
42. Gkogkas CG, Sonenberg N. Translational control and autism-like behaviors.
Cell Logist. 2013;3:e24551.
43. Laplante M, Sabatini DM. mTOR signaling in growth control and disease.
Cell. 2012;149:274–93.
44. Nairn AC, Bhagat B, Palfrey HC. Identification of calmodulin-dependent
protein kinase III and its major Mr 100,000 substrate in mammalian tissues.
Proc Natl Acad Sci U S A. 1985;82:7939–43.
45. Mitsui K, Brady M, Palfrey HC, Nairn AC. Purification and characterization of
calmodulin-dependent protein kinase III from rabbit reticulocytes and rat
pancreas. J Biol Chem. 1993;268:13422–33.
46. Ryazanov AG, Ward MD, Mendola CE, Pavur KS, Dorovkov MV, Wiedmann M,
et al. Identification of a new class of protein kinases represented by
eukaryotic elongation factor-2 kinase. Proc Natl Acad Sci U S A.
1997;94:4884–9.
47. Marin P, Nastiuk KL, Daniel N, Girault JA, Czernik AJ, Glowinski J, et al.
Glutamate-dependent phosphorylation of elongation factor-2 and inhibition
of protein synthesis in neurons. J Neurosci. 1997;17:3445–54.
48. Seibt J, Dumoulin MC, Aton SJ, Coleman T, Watson A, Naidoo N, et al.
Protein synthesis during sleep consolidates cortical plasticity in vivo. Curr
Biol. 2012;22:676–82.
49. Scheetz AJ, Nairn AC, Constantine-Paton M. NMDA receptor-mediated control
of protein synthesis at developing synapses. Nat Neurosci. 2000;3:211–6.
50. Park S, Park JM, Kim S, Kim JA, Shepherd JD, Smith-Hicks CL, et al. Elongation
factor 2 and fragile X mental retardation protein control the dynamic translation
of Arc/Arg3.1 essential for mGluR-LTD. Neuron. 2008;59:70–83.
51. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA
receptor blockade at rest triggers rapid behavioural antidepressant
responses. Nature. 2011;475:91–5.
52. Browne GJ, Proud CG. A novel mTOR-regulated phosphorylation site in
elongation factor 2 kinase modulates the activity of the kinase and its
binding to calmodulin. Mol Cell Biol. 2004;24:2986–97.
53. Vuppalanchi D, Willis DE, Twiss JL. Regulation of mRNA transport and
translation in axons. Results Probl Cell Differ. 2009;48:193–224.
54. Donnelly CJ, Fainzilber M, Twiss JL. Subcellular communication through
RNA transport and localized protein synthesis. Traffic. 2010;11:1498–505.
55. Medioni C, Ramialison M, Ephrussi A, Besse F. Imp promotes axonal
remodeling by regulating profilin mRNA during brain development. Curr
Biol. 2014;24:793–800.
56. Kim S, Coulombe PA. Emerging role for the cytoskeleton as an organizer
and regulator of translation. Nat Rev Mol Cell Biol. 2010;11:75–81.
57. Gross SR, Kinzy TG. Improper organization of the actin cytoskeleton affects
protein synthesis at initiation. Mol Cell Biol. 2007;27:1974–89.
58. Sotelo-Silveira J, Crispino M, Puppo A, Sotelo JR, Koenig E. Myelinated axons
contain beta-actin mRNA and ZBP-1 in periaxoplasmic ribosomal plaques
and depend on cyclic AMP and F-actin integrity for in vitro translation. J
Neurochem. 2008;104:545–57.
59. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-
regulated kinases: kinase activation by phosphoinositide-dependent
phosphorylation. Annu Rev Biochem. 1999;68:965–1014.
60. Pittman YR, Kandl K, Lewis M, Valente L, Kinzy TG. Coordination of
eukaryotic translation elongation factor 1A (eEF1A) function in actin
organization and translation elongation by the guanine nucleotide
exchange factor eEF1Balpha. J Biol Chem. 2009;284:4739–47.
61. Van Horck FP, Holt CE. A cytoskeletal platform for local translation in axons.
Sci Signal. 2008;1:pe11.
62. Hovland R, Hesketh JE, Pryme IF. The compartmentalization of protein
synthesis: importance of cytoskeleton and role in mRNA targeting. Int J
Biochem Cell Biol. 1996;28:1089–105.63. Lee S, Nahm M, Lee M, Kwon M, Kim E, Zadeh AD, et al. The F-actin-microtubule
crosslinker Shot is a platform for Krasavietz-mediated translational
regulation of midline axon repulsion. Development. 2007;134:1767–77.
64. Bassell GJ, Singer RH, Kosik KS. Association of poly(A) mRNA with
microtubules in cultured neurons. Neuron. 1994;12:571–82.
65. Shestakova EA, Motuz LP, Gavrilova LP. Co-localization of components of
the protein-synthesizing machinery with the cytoskeleton in G0-arrested
cells. Cell Biol Int. 1993;17:417–24.
66. Hamill D, Davis J, Drawbridge J, Suprenant KA. Polyribosome targeting to
microtubules: enrichment of specific mRNAs in a reconstituted microtubule
preparation from sea urchin embryos. J Cell Biol. 1994;127:973–84.
67. Bartoli KM, Jakovljevic J, Woolford Jr JL, Saunders WS. Kinesin molecular
motor Eg5 functions during polypeptide synthesis. Mol Biol Cell.
2011;22:3420–30.
68. Venticinque L, Jamieson KV, Meruelo D. Interactions between laminin
receptor and the cytoskeleton during translation and cell motility. PLoS
One. 2011;6:e15895.
69. Bentley D, Toroian-Raymond A. Disoriented pathfinding by pioneer neurone
growth cones deprived of filopodia by cytochalasin treatment. Nature.
1986;323:712–5.
70. Chien CB, Rosenthal DE, Harris WA, Holt CE. Navigational errors made by
growth cones without filopodia in the embryonic Xenopus brain. Neuron.
1993;11:237–51.
71. Dwivedy A, Gertler FB, Miller J, Holt CE, Lebrand C. Ena/VASP function in
retinal axons is required for terminal arborization but not pathway
navigation. Development. 2007;134:2137–46.
72. Kwon Y, Hofmann T, Montell C. Integration of phosphoinositide- and
calmodulin-mediated regulation of TRPC6. Mol Cell. 2007;25:491–503.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
